You are here

Stroke DOI:10.1161/STROKEAHA.111.643262

Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage.

Publication TypeJournal Article
Year of Publication2012
AuthorsH Brouwers, B, Biffi, A, Ayres, AM, Schwab, K, Cortellini, L, Romero, JM, Rost, NS, Viswanathan, A, Greenberg, SM, Rosand, J, Goldstein, JN
Date Published2012 Jun
KeywordsAged, Aged, 80 and over, Alleles, Apolipoproteins E, Cerebral Hemorrhage, Female, Genetic Predisposition to Disease, Genotype, Hematoma, Humans, Male, Middle Aged, Prospective Studies, Retrospective Studies

BACKGROUND AND PURPOSE: Hematoma volume is the most potent predictor of outcome in spontaneous intracerebral hemorrhage (ICH), and hematoma expansion after hospital presentation occurs in up to 40% of individuals. Among patients with lobar ICH, the apolipoprotein E (APOE) ε2 allele predicts larger hematoma volumes at presentation. We investigated whether the ε2 allele also identifies individuals at increased risk of hematoma expansion.

METHODS: We analyzed 510 patients with primary ICH and genetic data available from an ongoing prospective cohort study. Baseline and follow-up CT scans were assessed for ICH location and volume using computer-assisted volumetric methods.

RESULTS: Individuals with lobar ICH who possessed APOE ε2 were at increased risk for hematoma expansion (OR, 2.72; 95% CI, 1.19-6.23; P=0.009). The highest odds of expansion were in patients who qualified for the diagnosis of cerebral amyloid angiopathy-related ICH and carried the APOE ε2 allele (OR, 6.02; 95% CI, 1.60-22.58; P=0.008). There was no effect of ε2 on hematoma expansion in deep ICH and APOE ε4 had no effect on hematoma expansion in lobar or deep ICH.

CONCLUSIONS: Possession of APOE ε2 predisposes individuals with lobar ICH to hematoma expansion. This effect is even more pronounced in patients with amyloid angiopathy-related ICH, consistent with the ε2 allele's role in vascular amyloid deposition and vessel fragility.


Alternate JournalStroke
PubMed ID22535266
PubMed Central IDPMC3361564
Grant ListK23 NS064052 / NS / NINDS NIH HHS / United States
K23 NS059774 / NS / NINDS NIH HHS / United States
5K23NS059774 / NS / NINDS NIH HHS / United States
R01 NS059727-01A1 / NS / NINDS NIH HHS / United States
K23 NS059774-01A2 / NS / NINDS NIH HHS / United States
P50NS051343 / NS / NINDS NIH HHS / United States
P50 NS051343 / NS / NINDS NIH HHS / United States
R01 NS059727 / NS / NINDS NIH HHS / United States
R01NS059727 / NS / NINDS NIH HHS / United States
R01 NS073344 / NS / NINDS NIH HHS / United States